Literature DB >> 18080810

Mediation of beta-endorphin in andrographolide-induced plasma glucose-lowering action in type I diabetes-like animals.

Bu Chin Yu1, Cheng Kuei Chang, Chih Fen Su, Juei Tang Cheng.   

Abstract

In the present study, we investigated the mechanism(s) for glucose-lowering action of andrographolide in streptozotocin-induced diabetic rats (STZ-diabetic rats). Andrographolide lowered plasma glucose concentrations in a dose-dependent manner and increased plasma beta-endorphin-like immunoreactivity (BER) dose-dependently in diabetic rats. Both of these responses to andrographolide were abolished by the pretreatment of animals with prazosin or N-(2-(2-cyclopropylmethoxy) ethyl) 5-choro-alpha-dimethyl-1H-indole-3-thylamine (RS17053) at doses sufficient to block alpha1-adrenoceptors (ARs). Also, andrographolide enhanced BER release from isolated rat adrenal medulla in a concentration-related manner that could be abolished by alpha1-ARs antagonists. Bilateral adrenalectomy in STZ-diabetic rats eliminated the activities of andrographolide, including the plasma glucose-lowering effect and the plasma BER-elevating effect. Andrographolide failed to lower plasma glucose in the presence of opioid micro-receptor antagonists and in the opioid micro-receptor knockout diabetic mice. Treatment of STZ-diabetic rats with andrographolide resulted in the reduced expression of phosphoenolpyruvate carboxykinase (PEPCK) in liver and an increased expression of the glucose transporter subtype 4 (GLUT 4) in soleus muscle. These effects were also blocked by opioid micro-receptor antagonists. In conclusion, our results suggest that andrographolide may activate alpha1-ARs to enhance the secretion of beta-endorphin which can stimulate the opioid micro-receptors to reduce hepatic gluconeogenesis and to enhance the glucose uptake in soleus muscle, resulting in a decrease of plasma glucose in STZ-diabetic rats. However, the roles of other endogenous opioid peptides or the mixture of several opioid peptides in the activation of opioid micro-receptors associated with the plasma glucose-lowering action of andrographolide, should be considered and need more investigation in the future.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18080810     DOI: 10.1007/s00210-007-0240-0

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  37 in total

1.  Lipoic acid acutely induces hypoglycemia in fasting nondiabetic and diabetic rats.

Authors:  M Khamaisi; A Rudich; R Potashnik; H J Tritschler; A Gutman; N Bashan
Journal:  Metabolism       Date:  1999-04       Impact factor: 8.694

2.  Plasma glucose-lowering effect of beta-endorphin in streptozotocin-induced diabetic rats.

Authors:  J T Cheng; I M Liu; T F Tzeng; C C Tsai; T Y Lai
Journal:  Horm Metab Res       Date:  2002-10       Impact factor: 2.936

3.  Andrographolide prevents oxygen radical production by human neutrophils: possible mechanism(s) involved in its anti-inflammatory effect.

Authors:  Yuh-Chiang Shen; Chieh-Fu Chen; Wen-Fei Chiou
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

4.  Evidence for a hormonal action of beta-endorphin to increase glucose uptake in resting and contracting skeletal muscle.

Authors:  A A Evans; S Khan; M E Smith
Journal:  J Endocrinol       Date:  1997-11       Impact factor: 4.286

5.  Activation of alpha1A-adrenoceptor by andrographolide to increase glucose uptake in cultured myoblast C2C12 cells.

Authors:  Jen-Hao Hsu; Shorong-Shii Liou; Bu-Chin Yu; Juei-Tang Cheng; Yang-Chang Wu
Journal:  Planta Med       Date:  2004-12       Impact factor: 3.352

6.  Activation of imidazoline receptors in adrenal gland to lower plasma glucose in streptozotocin-induced diabetic rats.

Authors:  S-L Hwang; I-M Liu; T-F Tzeng; J-T Cheng
Journal:  Diabetologia       Date:  2005-03-09       Impact factor: 10.122

7.  Neuroanatomical sites mediating the central actions of beta-endorphin as mapped by changes in glucose utilization: involvement of mu opioid receptors.

Authors:  A Ableitner; R Schulz
Journal:  J Pharmacol Exp Ther       Date:  1992-07       Impact factor: 4.030

8.  beta-Endorphin and adrenocorticotropin are selected concomitantly by the pituitary gland.

Authors:  R Guillemin; T Vargo; J Rossier; S Minick; N Ling; C Rivier; W Vale; F Bloom
Journal:  Science       Date:  1977-09-30       Impact factor: 47.728

9.  The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity.

Authors:  Jaana Lindström; Anne Louheranta; Marjo Mannelin; Merja Rastas; Virpi Salminen; Johan Eriksson; Matti Uusitupa; Jaakko Tuomilehto
Journal:  Diabetes Care       Date:  2003-12       Impact factor: 19.112

10.  Antihyperglycemic effect of andrographolide in streptozotocin-induced diabetic rats.

Authors:  Bu-Chin Yu; Chen-Road Hung; Wang-Chuan Chen; Juei-Tang Cheng
Journal:  Planta Med       Date:  2003-12       Impact factor: 3.352

View more
  12 in total

1.  Immunomodulatory activity of andrographolide on macrophage activation and specific antibody response.

Authors:  Wei Wang; Jing Wang; Sheng-fu Dong; Chun-hong Liu; Paola Italiani; Shu-hui Sun; Jing Xu; Diana Boraschi; Shi-ping Ma; Di Qu
Journal:  Acta Pharmacol Sin       Date:  2010-02       Impact factor: 6.150

2.  Isolation and identification of bioactive compounds in Andrographis paniculata (Chuanxinlian).

Authors:  Wen-Wan Chao; Bi-Fong Lin
Journal:  Chin Med       Date:  2010-05-13       Impact factor: 5.455

Review 3.  Phytotherapy in diabetes: Review on potential mechanistic perspectives.

Authors:  Hanan S El-Abhar; Mona F Schaalan
Journal:  World J Diabetes       Date:  2014-04-15

4.  Antidiabetic and antihiperlipidemic effect of Andrographis paniculata (Burm. f.) Nees and andrographolide in high-fructose-fat-fed rats.

Authors:  Agung Endro Nugroho; Mohamad Andrie; Ni Kadek Warditiani; Eka Siswanto; Suwidjiyo Pramono; Endang Lukitaningsih
Journal:  Indian J Pharmacol       Date:  2012-05       Impact factor: 1.200

5.  Antihyperglycemic action of rhodiola-aqeous extract in type1-like diabetic rats.

Authors:  Chiang-Shan Niu; Li-Jen Chen; Ho-Shan Niu
Journal:  BMC Complement Altern Med       Date:  2014-01-13       Impact factor: 3.659

Review 6.  Andrographolide, a New Hope in the Prevention and Treatment of Metabolic Syndrome.

Authors:  Muhammad T Islam
Journal:  Front Pharmacol       Date:  2017-08-23       Impact factor: 5.810

7.  Diosmin, a Citrus Nutrient, Activates Imidazoline Receptors to Alleviate Blood Glucose and Lipids in Type 1-Like Diabetic Rats.

Authors:  Chia-Chen Hsu; Mang Hung Lin; Juei-Tang Cheng; Ming Chang Wu
Journal:  Nutrients       Date:  2017-06-30       Impact factor: 5.717

8.  Mediation of Endogenous β-Endorphin in the Plasma Glucose-Lowering Action of Herbal Products Observed in Type 1-Like Diabetic Rats.

Authors:  I M Liu; J T Cheng
Journal:  Evid Based Complement Alternat Med       Date:  2010-10-19       Impact factor: 2.629

9.  Hypoglycemic and beta cell protective effects of andrographolide analogue for diabetes treatment.

Authors:  Zaijun Zhang; Jie Jiang; Pei Yu; Xiangping Zeng; James W Larrick; Yuqiang Wang
Journal:  J Transl Med       Date:  2009-07-16       Impact factor: 5.531

Review 10.  Andrographis paniculata (Burm. f.) Wall. ex Nees: a review of ethnobotany, phytochemistry, and pharmacology.

Authors:  Md Sanower Hossain; Zannat Urbi; Abubakar Sule; K M Hafizur Rahman
Journal:  ScientificWorldJournal       Date:  2014-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.